Min MIn Qin
Chief Tech/Sci/R&D Officer en LEPU BIOPHARMA CO., LTD. .
Cargos activos de Min MIn Qin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LEPU BIOPHARMA CO., LTD. | Chief Tech/Sci/R&D Officer | 10/12/2020 | - |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The private company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Corporate Officer/Principal | - | - |
Historial de carrera de Min MIn Qin
Antiguos cargos conocidos de Min MIn Qin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
HBM HOLDINGS LIMITED | Corporate Officer/Principal | 01/03/2018 | 01/04/2019 |
WUXI BIOLOGICS (CAYMAN) INC. | Corporate Officer/Principal | 01/08/2017 | 01/03/2018 |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/10/2016 | 01/07/2017 |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Zhejiang Teruisi Pharmaceutical Co., Ltd. is a private company based in Zhejiang, China that engages in the production of cancer medicine. | Chief Tech/Sci/R&D Officer | 01/09/2015 | 01/10/2016 |
Shanghai JMT-BIO Technology Co., Ltd. | Chief Tech/Sci/R&D Officer | 01/09/2012 | 01/09/2015 |
FIVE PRIME THERAPEUTICS, INC. | Director/Board Member | 01/01/2005 | 01/08/2012 |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/05/1997 | 01/10/2004 |
Formación de Min MIn Qin.
University of Wisconsin | Doctorate Degree |
Northwest A&F University | Undergraduate Degree |
Estadísticas
Internacional
China | 8 |
Estados Unidos | 4 |
Islas Caimán | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Sectorial
Health Technology | 8 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
HBM HOLDINGS LIMITED | Health Technology |
LEPU BIOPHARMA CO., LTD. | Health Technology |
Empresas privadas | 5 |
---|---|
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
Shanghai JMT-BIO Technology Co., Ltd. | |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The private company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Zhejiang Teruisi Pharmaceutical Co., Ltd.
Zhejiang Teruisi Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Zhejiang Teruisi Pharmaceutical Co., Ltd. is a private company based in Zhejiang, China that engages in the production of cancer medicine. | Health Technology |
Jiangsu Pacific Meinuoke Pharmaceutical Co. Ltd. |
- Bolsa de valores
- Insiders
- Min MIn Qin
- Experiencia